Previous 10 |
Correvio Pharma (NASDAQ: CORV ): Q4 GAAP EPS of -$0.18 beats by $0.03 . More news on: Correvio Pharma Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...
Correvio Reports Fourth Quarter and Full Year 2018 Financial Results Canada NewsWire VANCOUVER, March 13, 2019 Company on Track to Resubmit Brinavess NDA in Q2 2019 Mark H.N. Corrigan , MD to Commence CEO Duties on March 14, 2019 Management to Host Conference Call and...
Correvio Announces Amendment To Term Loan With CRG-Managed Funds Canada NewsWire VANCOUVER, March 11, 2019 Amendment Provides for Up To an Additional $10 Million in Debt Funding NASDAQ: CORV TSX: CORV VANCOUVER , March 11, 2019 /CNW/ - Correvio...
NASDAQ: CORV TSX: CORV VANCOUVER , March 7, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Correvio management will present at the following upcoming in...
Correvio To Report Fourth Quarter And Full Year 2018 Financial Results On March 13, 2019 Canada NewsWire VANCOUVER, March 6, 2019 NASDAQ: CORV TSX: CORV Conference Call Scheduled for Wednesday, March 13, 2019 at 8:00 a.m. Eastern ( 5:00 a.m. Pacific) ...
NASDAQ: CORV TSX: CORV VANCOUVER , Feb. 21, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Correvio's management team will participate in 1-on-1 meeting...
NASDAQ: CORV TSX: CORV VANCOUVER , Feb. 7, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced the presentation of clinical data highlig...
News, Short Squeeze, Breakout and More Instantly...
Correvio Pharma Corp. Company Name:
CORV Stock Symbol:
NASDAQ Market:
Correvio Pharma Corp. Website:
NASDAQ: CORV TSX: CORV VANCOUVER , May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order...
Correvio Announces Results from Annual General and Special Meeting of Securityholders Canada NewsWire VANCOUVER, May 15, 2020 Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV TSX: CORV VANCOUVER , May 15, 2020 /CNW/ - Correvio Pharma Cor...
NASDAQ: CORV TSX: CORV VANCOUVER , May 6, 2020 /PRNewswire/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, released a report...